1 suspended. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Suspended 1 |
Follow Long COVID: new trials by email Literature Review of Long COVID trials Research Report on Long COVID
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues Liraglutide Pen Injector [Saxenda], Medication Diary - Multiple Sclerosis, Long COVID | Early Phase 1 | Suspended | University of Chicago | 30 | 2024-01-26 | 2026-03-30 |
Multiple Sclerosis (1) · Obesity (1) · Obesity, Morbid (1) · Post-Acute COVID-19 Syndrome (1)
Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Body Weight (1) · COVID-19 (1) · Chronic Disease (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Disease Attributes (1) · Immune System Diseases (1) · Infections (1) · Lung Diseases (1) · Nervous System Diseases (1) · Nidovirales Infections (1)
Liraglutide (1)
United States (1)
Adam DuVall, MD (1)